Thermo Fisher Scientific (HAM:TN8) Other Current Liabilities: €10,156 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HAM:TN8 Thermo Fisher Scientific Inc HAM:TN8
83 GF Score
Price €503.00
GF Value €523.30
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Thermo Fisher Scientific Other Current Liabilities?

Thermo Fisher Scientific HAM:TN8 -0.87% 83 Other Current Liabilities is €10,156 Mil as of Jun. 2026. GuruFocus rates HAM:TN8 with a GF Score™ of 83/100 and a GF Value™ of €523.30 (Fairly Valued). The stock has 8 warning signs investors should review.

Thermo Fisher Scientific's other current liabilities for the quarter that ended in Jun. 2026 was €10,156 Mil.

Thermo Fisher Scientific's quarterly other current liabilities stayed the same from Dec. 2025 (€0 Mil) to Mar. 2026 (€0 Mil) but then increased from Mar. 2026 (€0 Mil) to Jun. 2026 (€10,156 Mil).

Thermo Fisher Scientific's annual other current liabilities stayed the same from Dec. 2023 (€0 Mil) to Dec. 2024 (€0 Mil) but then increased from Dec. 2024 (€0 Mil) to Dec. 2025 (€0 Mil).

Thermo Fisher Scientific Other Current Liabilities Related Terms

Thermo Fisher Scientific Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Thermo Fisher Scientific's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thermo Fisher Scientific Other Current Liabilities Chart

Thermo Fisher Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.00 0.00 0.00 0.00

Thermo Fisher Scientific Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 0.00 0.00 0.00 10,156.47
HAM:TN8
83GF Score
Thermo Fisher Scientific Inc HAM:TN8
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thermo Fisher Scientific Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of €10,156 Mil mean?
Thermo Fisher Scientific (HAM:TN8) has a Other Current Liabilities of €10,156 Mil as of Jun. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Thermo Fisher Scientific.
Is Thermo Fisher Scientific's Other Current Liabilities too high?
Thermo Fisher Scientific's current Other Current Liabilities is €10,156 Mil. Overall, Thermo Fisher Scientific has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Thermo Fisher Scientific's Other Current Liabilities compare to DHR and IDXX?
Thermo Fisher Scientific's Other Current Liabilities of €10,156 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Diagnostics & Research company?
A good Other Current Liabilities depends on the Medical Diagnostics & Research industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Thermo Fisher Scientific. Thermo Fisher Scientific's current Other Current Liabilities is €10,156 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thermo Fisher Scientific stock overvalued right now?
Based on GuruFocus' analysis, Thermo Fisher Scientific (HAM:TN8) is currently considered Fairly Valued. The stock's GF Value™ is €523.30, compared to a current price of €503.00 — trading 3.9% below its estimated fair value. The current Other Current Liabilities is €10,156 Mil. Thermo Fisher Scientific's overall GF Score™ is 83/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Thermo Fisher Scientific (HAM:TN8), the current Other Current Liabilities is €10,156 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Thermo Fisher Scientific (HAM:TN8) Overvalued in 2026?

Based on GuruFocus' analysis, Thermo Fisher Scientific stock appears to be undervalued. The current stock price of €503.00 is trading 3.9% below its estimated GF Value™ of €523.30. GuruFocus considers Thermo Fisher Scientific to be Fairly Valued.

Key valuation signals for HAM:TN8:

  • Other Current Liabilities: €10,156 Mil
  • GF Value™: €523.30 vs. price of €503.00 (3.9% below fair value)
  • GF Score™: 83/100 with 8 warning signs

No single metric tells the full story. See the HAM:TN8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Thermo Fisher Scientific Business Description

Address 168 Third Avenue, Waltham, MA, USA, 02451
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
83GF Score

Get the complete analysis for HAM:TN8

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€503.00
Price
€523.30
GF Value